Is occult lymph node disease in colorectal cancer patients clinically significant? A review of the relevant literature.
about
GUCY2C reverse transcriptase PCR to stage pN0 colorectal cancer patientsSingle Nucleotide Polymorphisms as Prognostic and Predictive Factors of Adjuvant Chemotherapy in Colorectal Cancer of Stages I and IIMolecular biomarkers for the detection of metastatic colorectal cancer cellsGuanylyl cyclase C as a biomarker in colorectal cancerLong noncoding RNA expression profile analysis of colorectal cancer and metastatic lymph node based on microarray dataPrevistage GCC colorectal cancer staging test: a new molecular test to identify lymph node metastases and provide more accurate information about the stage of patients with colorectal cancer.Hsa-miR-19a is associated with lymph metastasis and mediates the TNF-α induced epithelial-to-mesenchymal transition in colorectal cancerPrevistage GCC test for staging patients with colorectal cancer.Current status of gene expression profiling to assist decision making in stage II colon cancerEvaluation of guanylyl cyclase C lymph node status for colon cancer staging and prognosis.The influence of micrometastases on prognosis and survival in stage I-II colon cancer patients: the Enroute⊕ Study.The significance of clinicopathological aspects of tumor for the detection of liver micrometastasis in patients with colorectal cancer.Immune cells: plastic players along colorectal cancer progressionThe uroguanylin system and human disease.Isolated tumor cells and circulating CK20 mRNA in pN0 colorectal cancer patients.Occult tumor burden predicts disease recurrence in lymph node-negative colorectal cancerBacterial heat-stable enterotoxins: translation of pathogenic peptides into novel targeted diagnostics and therapeutics.Occult tumor burden contributes to racial disparities in stage-specific colorectal cancer outcomes.Molecular staging individualizing cancer management.Isolated tumor cells in stage I & II colon cancer patients are associated with significantly worse disease-free and overall survivalAnalytic lymph node number establishes staging accuracy by occult tumor burden in colorectal cancer.Lymph node tissue kallikrein-related peptidase 6 mRNA: a progression marker for colorectal cancerGUCY2C molecular staging personalizes colorectal cancer patient managementMolecular investigation of lymph nodes in colon cancer patients using one-step nucleic acid amplification (OSNA): a new road to better staging?Molecular staging of node negative patients with colorectal cancer.Good and complete responding locally advanced rectal tumors after chemoradiotherapy: where are the residual positive nodes located on restaging MRI?Molecularly determined total tumour load in lymph nodes of stage I-II colon cancer patients correlates with high-risk factors. A multicentre prospective studyEx vivo sentinel node mapping in colon cancer combining blue dye staining and fluorescence imaging.Association of GUCY2C expression in lymph nodes with time to recurrence and disease-free survival in pN0 colorectal cancerLymph node staging in colorectal cancer: old controversies and recent advances.Long noncoding RNA GAPLINC promotes invasion in colorectal cancer by targeting SNAI2 through binding with PSF and NONO.Lymph node pooling: a feasible and efficient method of lymph node molecular staging in colorectal carcinoma.Endoscopic tattooing of early colon carcinoma enhances detection of lymph nodes most prone to harbor tumor burden.MicroRNA-194 modulates epithelial-mesenchymal transition in human colorectal cancer metastasisImpact on Prognosis of Lymph Node Micrometastasis and Isolated Tumor Cells in Stage II Colorectal Cancer.Lymph node CEA and MUC2 mRNA as useful predictors of outcome in colorectal cancer.Overexpression of ADAM9 Promotes Colon Cancer Cells Invasion.Single Nucleotide Polymorphisms in Genes MACC1, RAD18, MMP7 and SDF-1a As Prognostic Factors in Resectable Colorectal Cancer.Recurrence in patients with stage I colorectal cancer.Screening of lymph nodes metastasis associated lncRNAs in colorectal cancer patients.
P2860
Q24641833-00C2B1FE-420B-48AD-8C62-ED9C6EC9DDAAQ26765344-969FA327-6A80-45B1-82BC-B670B729B9D6Q27002450-CCBDDA82-FBFC-4D8E-81C4-359A14FB7996Q27011759-9D2CE3A2-A39E-4308-91C1-DFC25F1F9074Q31100562-161F2E76-F21F-43C2-949F-045194F83C81Q33427566-B190AEF5-09E5-4410-924E-3F92AEBC5724Q33552969-5AD6068C-BC8D-4846-9512-A2D93CCEE107Q33641600-CE21BE48-3E1B-4F44-AC07-AB0B8C4EDD93Q33829763-3B926B98-E8F5-4B3C-A16C-37EDD26C250CQ33887066-EBF7FF9A-2A0B-4B0A-ABFC-83AE81DDF32AQ33898741-578658A2-430B-4CFB-8CE1-A1AA65B246ABQ33977304-84E0111C-5EF8-4945-93F1-44E151EBC5EDQ33985586-43AFB93D-0295-4ECE-B35C-F783C10F68FEQ34293073-C537A4A2-1505-47DB-8005-1B4B35D533E8Q34767579-CDF2DC68-7AC6-40F5-A880-70ACDE2CC81AQ34988050-74B0C36D-8CB4-46D9-B3D9-6C6E23733F84Q35155933-B52BBAD6-80F8-44D1-8ACF-F069B36D5786Q35605899-4F1D65C9-40F5-4D35-B072-72E2C897739BQ35854173-703BBFFF-C951-4541-B6A8-81DD8292653DQ35924171-0536C09F-BF98-417D-9EEA-AE88E87FC5D2Q36016596-2542B772-7579-4450-8F02-06EE8B0CAE0EQ36075255-A3FA4EBB-0700-4114-8F1A-E8709D0D7157Q36336227-00AE2150-7BD0-420E-AAC0-AD7B7D8C6302Q36547205-E37F15F6-4070-4340-822B-406BDDCF7104Q36646525-12161329-6EA9-45E4-B6C8-17BACADBBC46Q37017653-9B7D56B4-A466-4C3B-ACEA-51E14ADD6290Q37277448-961C365F-8710-461B-9E9B-5B87E67525C7Q37299527-046FD47F-4A03-443E-9951-9E6A272A6203Q37372472-5269FBF7-6C49-4998-838B-BBC70FEF535AQ37408817-0F5F8606-02E9-41D4-A337-0CE738C0A2AFQ37520492-8B029A22-2BFC-4FFF-8133-4ADCA6AF5993Q37587123-165CBF80-FE8F-444A-AD70-B80F5CF5F686Q37607246-2CA322FE-251A-46AA-8531-9F23C7E66285Q37682846-8D1AD213-B2E0-45BB-83AD-197785982869Q38474003-01068D02-CBED-45A7-9073-8441BBA1FF1EQ39535135-8514EE3A-7B59-42AA-B3E1-C8277AB0EA21Q39916438-B6C9ED99-EB2D-4640-B246-BBCF5B2E9B8CQ40109815-24313FA3-BD09-4045-A749-DBC8EDD28360Q41520623-71BC50D9-2056-47E4-9052-CAFB56456D3AQ42720542-54B90F60-AF32-4329-9B17-3DC515498CA4
P2860
Is occult lymph node disease in colorectal cancer patients clinically significant? A review of the relevant literature.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Is occult lymph node disease i ...... ew of the relevant literature.
@ast
Is occult lymph node disease i ...... ew of the relevant literature.
@en
type
label
Is occult lymph node disease i ...... ew of the relevant literature.
@ast
Is occult lymph node disease i ...... ew of the relevant literature.
@en
prefLabel
Is occult lymph node disease i ...... ew of the relevant literature.
@ast
Is occult lymph node disease i ...... ew of the relevant literature.
@en
P2093
P2860
P921
P1476
Is occult lymph node disease i ...... iew of the relevant literature
@en
P2093
Daniel G Nicastri
John T Doucette
Steven J Hughes
P2860
P304
P356
10.2353/JMOLDX.2007.070032
P577
2007-10-04T00:00:00Z